Inventor

HANKE TOMAS

GB10 patents

⚠️ This page may combine multiple inventors who share the name “HANKE TOMAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MEDICAL RES COUNCIL

2 patents

US7993651B2Aug 9, 2011

Chimeric human immunodeficiency virus (HIV) immunogens comprising GAG P24-P17 fused to multiple cytotoxic T lymphocyte (CTL) epitopes

MEDICAL RES COUNCIL11 citations81

US7981430B2Jul 19, 2011

Multi-clade chimeric immunogens derived from highly conserved regions of the human immunodeficiency virus type 1 (HIV-1) consensus proteome

MEDICAL RES COUNCIL11 citations80

LOS ALAMOS NAT SECURITY LLC

2 patents

US10010606B2Jul 3, 2018

Mosaic conserved region HIV immunogenic polypeptides

LOS ALAMOS NAT SECURITY LLC2 citations70

US11235055B2Feb 1, 2022

Nucleic acids encoding mosaic conserved region HIV immunogenic polypeptides

LOS ALAMOS NAT SECURITY LLC0 citations60

TRIAD NAT SECURITY LLC

2 patents

US12364750B1Jul 22, 2025

Conserved region T cell vaccines for coronavirus and methods of use

TRIAD NAT SECURITY LLC0 citations60

US12023376B1Jul 2, 2024

Conserved region T cell vaccines for coronavirus and methods of use

TRIAD NAT SECURITY LLC0 citations60

OXXON THERAPEUTICS LTD

2 patents

US7514087B2Apr 7, 2009

Methods and reagents for immunization which generate a CD8 T cell immune response

OXXON THERAPEUTICS LTD4 citations59

US7407661B2Aug 5, 2008

Methods and reagents that generate a CD8 T cell immune response

OXXON THERAPEUTICS LTD4 citations59

OXXON PHARMACCINES LTD

1 patent

US6663871B1Dec 16, 2003

Methods and reagents for vaccination which generate a CD8 T cell immune response

OXXON PHARMACCINES LTD47 citations91

HANKE TOMAS

1 patent

US8728485B2May 20, 2014

Peptide library obtained from multi-clade chimeric immunogens derived from highly conserved regions of the human immunodeficiency virus type 1 (HIV-1) consensus proteome

HANKE TOMAS0 citations42